iCAD to Participate in Two Upcoming Investor Conferences
May 22, 2017 12:03 pm UTC| Business
NASHUA, N.H., May 22, 2017 -- iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today...
iCAD to Participate in Two Upcoming Investor Conferences
May 22, 2017 12:03 pm UTC| Business
NASHUA, N.H., May 22, 2017 -- iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today...
Spark Energy, Inc. Announces New $120 Million Credit Facility
May 22, 2017 12:02 pm UTC| Business
HOUSTON, May 22, 2017 -- Spark Energy, Inc. (NASDAQ:SPKE), a Delaware corporation ("Spark" or the “Company”), announced today the closing of a new $120 million senior secured borrowing base credit facility (the...
Spark Energy, Inc. Announces New $120 Million Credit Facility
May 22, 2017 12:02 pm UTC| Business
HOUSTON, May 22, 2017 -- Spark Energy, Inc. (NASDAQ:SPKE), a Delaware corporation ("Spark" or the “Company”), announced today the closing of a new $120 million senior secured borrowing base credit facility (the...
May 22, 2017 12:02 pm UTC| Business
CHICAGO, May 22, 2017 -- Vivid Seats, the largest independent online ticket marketplace, today released its pricing preview for the top-selling live music events of the 2017 summer season. From legendary classics to...
JLT Specialty USA Announces Appointment of Denise Kaloudis as Senior Vice President
May 22, 2017 12:02 pm UTC| Business
NEW YORK, May 22, 2017 -- JLT Specialty USA, a U.S. subsidiary of Jardine Lloyd Thompson Group plc. (JLT), one of the world’s leading specialty-focused providers of insurance, reinsurance and employee benefits related...
Tetraphase Pharmaceuticals to Present Antibiotics Pipeline Data at ASM Microbe 2017
May 22, 2017 12:02 pm UTC| Business
Eleven Abstracts Selected for Presentation, Including Four Highlighting Pharmacokinetic and Global Surveillance Data for Eravacycline TP-6076 Phase 1 Single-Ascending Dose Data Selected for Oral Presentation; TP-271...